Buy Kezar Life Sciences Inc Stock | KZR Stock Price & Latest News | Public
KZR

Kezar Life Sciences Inc

$0.00 (0.00%)Today
    Small Market Cap

    About KZR

    Kezar Life Sciences, Inc. is a clinical-stage biotechnology company, which engages in the development of novel small molecule therapeutics to treat autoimmunity and cancer in South San Francisco, California. Its product pipeline include KZR-616, KZR-261, and KZR-TBD. Th...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.1
    -0.2
    -0.31
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.23

    Actual EPS
    Q4 2020

    Stats

    Market Cap$260,95M
    Volume9,11k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$9.79
    1 Year Low$2.18
    Open$5.73
    High$5.73
    Low$5.42

    Buy any stock with any amount of money.

    Download the App
    Download the app